Canopy (TSX:WEED) Warnings Could Signal Explosive Marijuana Growth in 2020

Canopy Growth stock’s recent rallying performance might signal a resurgence for the beleaguered legal weed industry.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis industry never ceases to amaze investors and analysts alike with its remarkable highs and devastating lows. Calling things less than pretty for weed stocks in 2019 is an understatement. Publically traded legal weed companies across the board declined drastically in 2019. Are you curious about what is happening right now?

Canopy woes might be over

I repeatedly talked about moving away from the cannabis sector to more secure investments. Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) might be making moves to make me want to forget that.

The stock recently soared by over 15% last Friday, after the weed producer reported good results from its Q3 2019 earnings. The company reported a 62% sequential net revenue growth, seeing the company’s net earnings increase to almost $124 million in the third quarter of fiscal 2019 that ended in December 2019.

The $123.8 million net earnings in the quarter beat analyst expectations at around $105.4 million. Analysts also expected that Canopy would report an adjusted EBITDA loss of $110 million as opposed to the $91.7 million. The overall operating costs also fell in the third quarter of fiscal 2019 for Canopy by 14% compared to the previous quarter.

Prior changes showing results

Canopy has made several changes in its recent past to adjust to the situation in the market for cannabis stocks. The company hired CEO David Klein after a six-month-long search to replace founder and co-CEO Bruce Linton.

David Klein says that despite the positive results, the company still has plenty to do so that it can pave a proper path toward profitability.

The company has been taking steps to reduce costs and prioritize the re-scaling of the business to a level where it can improve cash flow and profit margins. The company enacted reduced stock-based compensation in the current fiscal year as well as cost controls to this end.

Analysts expect that the recent quarterly earnings growth shows signs of life for the marijuana industry. The result demonstrates that Canopy can potentially produce gross margins in the region of 40% by the end of Q4 2019. New leadership and improved financial discipline have a great deal to do with the cleaner earnings report.

Improved cash flow in domestic and international markets

The weed producer reported better financial results across its local and international markets. The company has a leading 22% share of recreational weed sales in Canada. Its recreational pot business rose 9% from the previous quarter in the domestic market.

Canopy’s revenue in international cannabis markets increased by 3% in Q3 2019 to reach $18.7 million. The company sold more than 13,000 kilograms of cannabis in the quarter, rising above the 10,913 kilograms recorded in the prior quarter.

Canopy also reduced the amount of marijuana it harvested from 40,750kg in the previous quarter to 29,920 kilograms — an indication that Canopy is tackling the oversupply issue.

Foolish takeaway

At writing, the Canopy stock is trading for $29.08 per share. While a far cry from its all-time highs, it was up 43.18 from its 52-week low in November 2019.

While there is some promise in the weed sector thanks to Canopy Growth’s recent quarterly earnings report, but I would still be wary of how many eggs I would put in this basket.

If you want to consider investing in the weed sector, perhaps a speculative investment at best should be the way to go.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »